13F-HR filed by Stonepine Capital Management, LLC
Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-13, with 25 holding rows worth $108,898,692.
- Accession
- 0000935836-24-000513
- Filer
- CIK 1440771
- Filed
- 2024-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 25 entries on the cover page, a total value of $108,898,692 stated on the cover page (in dollars after the unit check, H1), rows summing to $108,898,692 with VALUE read as dollars as filed, 13F file number 028-17175. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ADMA BIOLOGICS INC | 000899104 | COM | 1,870,000 | $20,906,600 | dollars as filed | |
| ALIMERA SCIENCES INC | 016259202 | COM | 3,511,816 | $19,525,697 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 1,657,611 | $17,985,079 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 485,000 | $12,018,300 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 2,800,000 | $7,196,000 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 250,129 | $5,925,556 | dollars as filed | |
| ANIKA THERAPEUTICS INC | 035255108 | COM | 165,397 | $4,189,506 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 625,645 | $2,940,532 | dollars as filed | |
| RIGEL PHARMACEUTICALS INC | 766559702 | COMMON STOCK | 305,000 | $2,507,100 | dollars as filed | |
| OPTINOSE INC | 68404V100 | COM | 2,350,010 | $2,444,010 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,927,446 | $2,120,191 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 421,703 | $1,834,408 | dollars as filed | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 300,000 | $1,713,000 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 1,239,199 | $1,635,743 | dollars as filed | |
| AYTU BIOPHARMA INC | 054754858 | COM | 472,469 | $1,379,609 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T309 | COMMON | 200,000 | $840,000 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 609,446 | $737,430 | dollars as filed | |
| EXAGEN INC | 30068X103 | COM | 358,697 | $652,829 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,050,452 | $630,271 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 137,174 | $558,298 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 100,000 | $385,000 | dollars as filed | |
| ETON PHARMACEUTICALS INC | 29772L108 | COMMON STOCK | 110,000 | $361,900 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 48,012 | $313,038 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 5,000 | $81,250 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 1,584 | $17,345 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000935836-24-000513 | this filing | 2024-08-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000935836-24-000540 | base | 2024-08-21 | acceptance time not in the bulk data set |